Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,299 papers from all fields of science
Search
Sign In
Create Free Account
Malignant neoplasm of stomach stage III
Known as:
Stage III Gastric Cancer
, Stage III Gastric Cancer AJCC v7
, gastric cancer, stage III
Expand
Stage III includes: IIIA (T4a, N1, M0); (T3, N2, M0); (T2, N3, M0); IIIB (T4b, N0, M0); (T4b, N1, M0); (T4a, N2, M0); (T3, N3, M0); IIIC (T4b, N2, M0…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Epithelial Cells
Epithelium
Gastric mucosa
Gastrointestinal system
Expand
Narrower (1)
Stage III Carcinoma of Stomach
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A randomized phase III study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer (JACCRO GC-07 trial).
Y. Kodera
,
Kazuhiro Yoshida
,
+17 authors
M. Fujii
2018
Corpus ID: 81186282
4007Background: Although postoperative adjuvant chemotherapy with S-1 is among the standard treatments for curatively resected…
Expand
2018
2018
Prognostic value of preoperative prognostic nutritional index in stage III gastric cancer after curative resection: a retrospective cohort study.
Huaxi Wang
,
Cunchuan Wang
,
Wah Yang
,
Lilian Gao
,
Shu-qing Yu
Asia Pacific Journal of Clinical Nutrition
2018
Corpus ID: 13690807
BACKGROUND AND OBJECTIVES Nutrition and inflammation play a crucial role in the development of cancer. The prognostic value of…
Expand
2018
2018
A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer
Yusaku Tanaka
,
C. Kunisaki
,
+10 authors
I. Endo
Anticancer Research
2018
Corpus ID: 52897657
Background/Aim: The aim of this phase I/II study was to determine the safety, and efficacy of combination of neoadjuvant…
Expand
2017
2017
Comparison of the 7th and 8th editions of the American joint committee on cancer TNM classification for patients with stage III gastric cancer.
Jun Lu
,
C. Zheng
,
+8 authors
Chang-ming Huang
OncoTarget
2017
Corpus ID: 318365
BACKGROUND AND OBJECTIVES The eighth TNM edition for gastric cancer was released in 2016 and included major revisions, especially…
Expand
2017
2017
Comparison of the 7th and 8th editions of the American joint committee on cancer TNM classification for patients with stage III gastric cancer
Jun Lu
,
C. Zheng
,
+8 authors
Chang-ming Huang
OncoTarget
2017
Corpus ID: 54611596
Background and Objectives The eighth TNM edition for gastric cancer was released in 2016 and included major revisions, especially…
Expand
2017
2017
699PThe effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of stage III gastric cancer patients: A comparative study between the 7th and 8th…
J. Lu
,
H. Chang-ming
,
C. Zheng
,
Q. Chen
,
R. Tu
2017
Corpus ID: 80467873
2016
2016
Expression of tumor necrosis factor-α-induced protein 8 in stage III gastric cancer and the correlation with DcR3 and ERK1/2.
Ruyi Hu
,
Wenming Liu
,
+7 authors
Zhong-chen Liu
Oncology Letters
2016
Corpus ID: 23127809
Tumor necrosis factor (TNF)-α-induced protein 8 (TIPE) is a recently identified protein that is considered to be associated with…
Expand
2016
2016
An update on the randomized phase III POST trial: S-1 based doublet as an adjuvant chemotherapy for curatively resected stage III gastric cancer.
Choong-kun Lee
,
M. Jung
,
+15 authors
S. Rha
2016
Corpus ID: 80847366
4042Background: We report an updated results from a randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS…
Expand
2011
2011
Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy
S. Tamura
,
K. Fujitani
,
+8 authors
H. Furukawa
Oncology
2011
Corpus ID: 37868923
Objective: The aim of this prospective study was to evaluate the feasibility and safety of adjuvant S-1 plus docetaxel in…
Expand
1988
1988
STUDY ON THE EFFECT OF POST-OPERATIVE ADJUVANT CHEMOTHERAPY FOR THE PATIENTS WITH STAGE III GASTRIC CANCER
Tanji Suzuki
,
G. Nakano
,
K. Mukawa
,
K. Sakamoto
,
T. Kurihara
,
Y. Nagamachi
1988
Corpus ID: 59102066
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required